The Pennsylvania Breast Cancer Coalition is celebrating 30 years.
A VERIFY reader asked if the latest COVID shots are approved by the FDA, which means they meet the agency’s most thorough standards for safety and efficacy.FILE - Pfizer, left, and Moderna bivalent COVID-19 vaccines are readied for use at a clinic in Richmond, Va.
Since the COVID-19 vaccines were first rolled out in 2020, they have been at different stages of emergency use authorization and U.S. Food and Drug Administration approval, and it's been difficult for some to keep track of where they all stand.The updated Pfizer and Moderna mRNA COVID-19 vaccines are fully approved by the FDA for people age 12 and older. Both vaccines are also authorized for emergency use for children ages 6 months to 11 years old.
Starting at age 5, the FDA said that most people can get a single dose of the updated Pfizer or Moderna vaccines even if they’ve never had a prior COVID-19 shot. Younger children might need additional doses depending on their history of COVID-19 infections and vaccinations.for emergency use in people 12 years of age and older on Oct. 3, 2023.
“The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness and manufacturing quality,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “We very much encourage those who are eligible to consider getting vaccinated.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna confirms COVID sales guidance as shares sink on Pfizer newsCompany sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain
Read more »
Stock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester UnitedLululemon stock climbs ahead of S&P 500 inclusion
Read more »
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Pfizer, Moderna, Schwab, Instacart, D.R. Horton, Tesla, and More Stock Market MoversPfizer slashes revenue expectations, Charles Schwab's adjusted earnings beat estimates, and Lululemon will be joining the S&P 500 on Wednesday.
Read more »
Pfizer slumps after slashing full-year profit forecast on tumbling Covid salesPfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.
Read more »